Irvingia gabonensis (Aubry-Lacomate Ex. Ororke), Baill (African wild mango/bush mango) seeds are widely used in cooking as a sauce in Cameroon and in most parts of tropical Africa for the treatment of a number of ailments. In this study normal rat food was incorporated with I. gabonensis seed powder (10%) and oil free seed powder (5%) and their chronic effects on streptozotocin induced Type 2 diabetic rats were studied. Oral consumption of food incorporated with seed powder significantly reduced serum glucose level on the 28th day (p<0.01) which was comparable with glibenclamide treated group. Food with oil free seed powder showed 24% fall in glucose level on the 28 th day. Fasting serum insulin increased significantly (p<0.001) in glibenclamide and oil free seed powder treated (p<0.008) groups. No effect was observed in the seed powder treated group. Liver glycogen content increased in the glibenclamide treated group but no significant change was observed in both powder and oil free seed powder treated groups. On the 28 th day seed powder treated group significantly lowered serum TG level (p<0.033) and 48%
INTRODUCTION
The prevalence of diabetes is increasing globally. It has been predicted that the number of diabetics will be 300 million or more by the year 2025. 1 Furthermore, it is acknowledged that diabetes not only afflicts prosperous nations, but also often reaches its highest frequency in poor and disadvantaged communities, those which can least afford the heavy burden of its costly long-term treatment. Biguanides, derived from Galega officinalis is an excellent example of antidiabetic drug developed from plants 2 19-24, 2012 (June) pharmacokinetic properties, secondary failure rates and accompanying side effects. 3 Natural products have been a source of medicinal treatment for thousands of years and plant based medicines continue to play an important role in the primary health care of 80% of worlds underdeveloped and developing countries. In continuation of our search for new leading compounding (s) to have antidiabetic property, and collaboration with the scientists of Cameroon 4 we studied the antidiabetic effect of African mango seeds.
Irvingia gabonensis (African mango), locally known in Nigeria as agbono 5 , in Cameroon as andok, in Sierra Leone as bobo, belongs to the Irvingiaceae family. The fruits of I. gabonensis are rich in oil (54-64%) 6 and are commonly used in making a paste called 'dika'. The bark is used for the treatment of colic, diarrhea and dysentery. 7 In Sierra Leone, the Mende tribes grind the steam bark and mix it with water and apply the paste on the skin to ameliorate pain. 8 African mango seed has folkloric use to reduce body mass weight, (BMW), popular as blood thinner (blood anticoagulant effect) and are effective for diabetes and are available in the Western countries and North America over the counter. In this case, scientific studies are made to evaluate the claim. The aim of this study was to assess the chronic effect of I. gabonensis seed powder and oil free seed powder on body weight, serum glucose, lipid profile, serum insulin and liver glycogen content in Type 2 diabetic model rats.
MATERIALS AND METHODS

Collection of I. gabonensis (seeds).
The seeds of I. gabonensis were brought by one of the coauthors from Cameroon. The voucher sample (No 28054/HNC) has been kept in the National Herbarium of Cameroon. After peeling, the seeds were dried in an oven at 40 0 C for 24 hours and powdered with motor and pestle of mesh size 100. Normal rat food was incorporated with crude powder of I. gabonensis (10%) and used for testing the biological activity.
Extraction. The seed powder (1.5 kg) of I. gabonensis was extracted with hexane at room temperature for 24 hours and solvent was removed. The residue was extracted again with hexane two times more. All extracts were mixed and dried completely by rotavapor and seed powder was collected. Normal rat food was incorporated with oil free seed powder of I. gabonensis (5%) and used for biological testing.
Animals.
Male Long Evans rats, bred at BIRDEM animal house and weighing between 180-200 g were used in the study. Type 2 diabetic model of rats were produced with intraperitoneal injection of streptozotocin using conventional methods and following the procedure standardized in BIRDEM. 9 To carry out the experiment, Type 2 diabetic rats were divided into four groups; (i) Control group receiving normal food. (ii) Treated with standard drug glibenclamide (5 mg/kg body wt, once daily for 28 consecutive days). (iii) Treated with food containing seed powder (crude powder) of I. gabonensis, 10%). (iv) Treated with food containing oil free seed powder of I. gabonensis, 5%, for 28 consecutive days). Number of rats in each group was 6.
Blood collection and analytical procedure.
After an overnight fast, blood was collected by cutting the tail tip at the beginning and middle (14 th day) of the study period under mild ether anesthesia and by decapitation after 28 days. The serum was separated by centrifugation at 3000 rpm for 15 min. The clear non-hemolyzed supernatant fresh serum was then carefully taken into a set of clean, dried and sterilized glass vials. Serum glucose was estimated by glucose-oxidase (GOD-PAP) method. 10 Serum insulin was measured by a rat insulin ELISA kit.
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Total serum cholesterol and triglyceride (TG) were determined by enzymetic-colorimetric (Cholesterol CHOD-PAP) method. 12, 13 On the 28 th day after decapitation, abdomen was opened by laporotomy and liver was taken out, washed in ice-cold saline, patted dry and processed for glycogen estimation. Liver glycogen was measured by anthrone-reagent method.
14 Statistical analysis. Statistical analysis was performed using Statistical Package for Social Sciences (SPSS, version 12, Chicago, IL, USA). Results are expressed as mean ± SD for a given number of observations (n). Statistical evaluation of data was performed by using one-way analysis of variance (ANOVA) followed by Duncan's test. 15 The level of significance was set at 0.05.
RESULTS AND DISCUSSION
Effects of I. gabonensis seed powder and oil free seed powder on body weight (B.W.) of Type 2 diabetic model rats is presented in There was a 48% decrease in the serum TG level after 28 days feeding of I. gabonensis oil free seed (5%) although the fall was not significant. On the contrary, serum cholesterol level was increased by both the treated groups with I. gabonensis after 28 days of feeding although glibenclamide lowered the cholesterol level on 28 days. The crude powder (10%) and oil free extract (5%) of I. gabonensis seed was incorporated in the normal food of rats for 28 days. The findings on the body wt. of Type 2 diabetic model rats showed no significant effects (an increase of 2-4% was noticed). On the contrary, it was claimed that I. gabonensis seeds significantly reduces body wt. in obese subjects. 16 Our Type 2 diabetic rats were not obese, probably that is the reason why no change was observed in body weight during the treatment period. I. gabonensis was evaluated for biological activities including diabetes and significant blood glucose lowering effect was found in Type I diabetic model rats. [16] [17] I. gabonensis seed crude powder as well as extract lowered blood glucose level in Type 2 diabetic model rats. Administration of I. gabonensis seed crude powder significantly decreased the blood glucose level in these rats suggesting that it has hypoglycemic properties. Our results are in accordance with the findings of other investigators where it has been claimed that three weeks consumption of a viscous preparation of I. gabonensis resulted in a decreased blood glucose (P<0.05), pyruvate kinase and lactate dehydrogenase activities (P<0.05); and also increased glucose-6-phosphatase activity (P<0.05) in dikanut-fed diabetic rats compared with others not fed dikanuts. 18 It is well established that dyslipidemia, especially hypertriglyceridemia is a common finding in patients with diabetes mellitus and is responsible for vascular complications. 19 It has also been claimed that deficiency of lipoprotein lipase activity may contribute significantly to the elevation of triglyceroides in diabetes. 20 The effects of the seeds of I. gabonensis on serum lipids was studied and it was found that obese subjects under I. gabonensis treatment for 4 weeks had a significant decrease in total cholesterol, triglycerides, LDL-cholesterol and an increase in HDL-cholesterol. 17 Significant (P<0.05) decrease in serum Tg level by I. gabonensis powder and 48% decrease by oil free seed extract were also observed in our experiment. This decrease in triglyceroides level by I. gabonensis seeds may be due to control of hydrolysis of certain lipoproteins and their selective uptake and metabolism by different tissues. However, serum total cholesterol increased by both of them which is not beneficial. This increase in total cholesterol yet remains to be explained. It is known that I. gabonensis seeds may contain soluble dietary fibers that are bulk-forming laxatives. It is well established that dietary fibers delay stomach emptying; leading to a more gradual absorption of dietary 18 sugar which is probably responsible for glucose lowering effect seen in Type 2 diabetic model rats with the treatment of I. gabonensis seeds (both powder and extract).
Moreover, it has got insulinomimetic effect since I. gabonensis powder significantly increased serum insulin level. Hence, in addition to dietary fiber effect, it has insulinomimetic or insulin sensitizing effect. Since the seeds did not change liver glycogen contents significantly, therefore it seems that lowering of blood glucose by I. gabonensis seeds is not accomplished through glycogenesis.
CONCLUSIONS
The obtained results suggest that I. gabonensis seed powder as well as extract lowered blood glucose level in Type 2 diabetic model rats. In addition to dietary fiber like action it seems to act as an insulinomimetic and/or insulin sensitizing agent. The plant has triglyceride lowering effect. The plant merits further exploration both chemically and biologically to identify the active principle(s) and mechanism of action.
